| 1. |
- Lundstig, Annika, et al.
(författare)
-
No detection of SV40 DNA in mesothelioma tissues from a high incidence area in Sweden.
- 2007
-
Ingår i: Anticancer research. - 1791-7530 .- 0250-7005. ; 27:6B, s. 4159-4161
-
Tidskriftsartikel (refereegranskat)abstract
- Simian virus 40 (SV40), a polyoma virus of the rhesus macaque was discovered in 1960 as a contaminant of human polio vaccines produced in monkey cells. A number of studies have reported the detection of SV40 nucleotide sequences in human tumors, mainly mesotheliomas, but the reports have not been consistent. The presence of SV40 in 26 consecutive cases of malignant mesothelioma of biphasic type was investigated using a SV40 quantitative real time polymerase chain reaction (PCR) with a sensitivity of 10 copies of viral DNA per sample. All the samples were also tested for amplifiability using a real-time PCR for the beta-globin gene. Eighteen tumors were amplifiable, but none contained SV40 DNA. The results do not support an association between mesothelioma and SV40.
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
- Lundstig, Annika
(författare)
-
Polyomavirus infections in humans
- 2007
-
Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
- The human polyomaviruses BKV and JCV are endemic and infect > 70% of population worldwide. Primary infections occur during childhood and are largely subclinical. Following primary infection, both viruses persist as latent infections in the kidneys and B lymphocytes. Under conditions of severe immunosuppression like leukaemia, organ transplantation and AIDS, the viruses can reactivate and cause diseases. BKV is mainly related to urinary tract diseases and JCV is the causative agent of progressive multifocal leukoencephalopathy (PML). The human polyomaviruses have oncogenic potential and a possible association of with human cancer has been reported. JCV has been detected in certain brain tumours, in particular oligoastrocytoma and BKV has been detected in a variety of tumours, including neuroblastoma. Simian virus 40 (SV40), of rhesus monkey origin was accidentally introduced to humans through contaminated polio vaccine. Several studies have detected SV40 sequences in human tumours, mainly mesothelioma, osteosarcoma, ependymomas and choroid plexus tumours. The aim of the thesis was to study the infections of polyomaviruses in humans and their role in human cancers. We have established a VLP-based EIA BKV, JCV and SV40. Sera from Swedish children showed that BKV and JCV increased by age. Seropositivity was generally stable over time in serial samples. Analysis of maternal sera using both serology and DNA detection, found no evidence for association between BKV or JCV infection during pregnancy and an increased risk of developing neuroblastoma in the child. Sera from 386 cases of colorectal cancer and controls were investigated for JCV and BKV IgG seropositivity. The serologic assay used was validated within the study and found to have very high sensitivity for detecting subjects with polyoma virus shedding. Our study found no evidence for association between infection with the human polyomaviruses and excess risk for colorectal cancer. A low prevalence (7.6%) of SV40-specific antibodies was detected in the Nordic population. None of the SV40-seropositive samples contained detectable SV40 DNA. The investigation of 28 malignant mesothelioma tissues from deceased patients in Sweden found no detectable SV40 DNA. In summary, modern assays to detect polyomavirus antibodies and DNA has been established. We have now knowledge of the presence and age-specific prevalence of BKV, JCV and SV40 in Nordic countries. We did not confirm any association between infection with polyomaviruses and cancer.
|
|
| 6. |
- Lundstig, Annika, et al.
(författare)
-
Prevalence and stability of human serum antibodies to simian virus 40 VP1 virus-like particles.
- 2005
-
Ingår i: Journal of General Virology. - : Microbiology Society. - 1465-2099 .- 0022-1317. ; 86:Pt 6, s. 1703-1708
-
Tidskriftsartikel (refereegranskat)abstract
- Possible human infection with simian virus 40 (SV40) has been of great concern ever since SV40 was discovered in polio vaccines. Human populations are SV40-seropositive, but because of serological cross-reactivity between SV40 and the human polyomaviruses BK virus (BKV) and JC virus (JCV), it is debatable whether these antibodies are specific. An SV40-specific serological assay was established, based on purified virus-like particles (VLPs), where the SV40 VLPs were blocked with hyperimmune sera to BKV and JCV. Competition with SV40 hyperimmune sera was used as a confirmatory test. Among 288 Swedish children of between 1 and 13 years of age, 7·6 % had SV40-specific antibodies. SV40 seroprevalence reached a peak of 14 % at 7–9 years of age. Among 100 control patients with benign tumours, 9 % were SV40-seropositive. However, SV40 DNA was not detectable in corresponding buffy-coat samples. In serial samples taken up to 5 years apart from 141 Finnish women participating in the population-based serological screening for congenital infections, only two of 141 women were SV40-seropositive in both samples. Six women seroconverted and eight women had a loss of antibodies over time. None of the SV40-seropositive samples contained detectable SV40 DNA. In conclusion, there is a low prevalence of SV40-specific antibodies in the Nordic population. The SV40 antibodies appear to have a low stability over time and their origin is not clear.
|
|
| 7. |
- Lundstig, Annika, et al.
(författare)
-
Serological diagnosis of human polyomavirus infection
- 2006
-
Ingår i: Polyomaviruses and human diseases. - New York, NY : Springer New York. - 0387292330 ; 577, s. 96-101
-
Bokkapitel (övrigt vetenskapligt/konstnärligt)abstract
- Measurement of antibody titres to the human polyomaviruses BK and JC has for many years had to rely on Hemagglutination inhibition. In recent years, viral serology based on virus-like particles (VLPs) in enzyme immunoassays (EIAs) has become widely used for a variety of viruses. We sought to establish a modern method for serological diagnosis of BK and JC viruses, by using purified VLPs containing the VP1 major capsid proteins. Antibody titres in assays based on VLPs of BKV (strain SB) showed no correlation to the titres in similar JCV assays. BKV (SB) seropositivity increases rapidly with increasing age of the children and reaches a 98 % seroprevalence at 7–9 years of age, whereas JCV seroprevalences increase more slowly with increasing age reaching 51% positivity among children 9–11 years of age. The antibody levels are almost identical in serial samples taken up to 5 years apart, suggesting that both BKV and JCV VLP seropositivitities are usually stable over time and can be used to measure cumulative exposure to these viruses. Serology using SV40 VLPs showed strong cross-reactivity with human polyomaviruses, in particular with BKV strain AS, and establishing a specific VLP-based serology assay for SV40 required blocking with several hyperimmune sera to the human polyomaviruses. SV40-specific seropositivity also increased with increasing age of children, reaching 14% seroprevalence among children 7–9 years of age, but had limited stability over time in serial samples.
|
|
